Welcome to medications.com

Zegerid News

SmallCapStockAnalyst.com: Nacel Energy Corp Discusses Wind Energy ... - Trading Markets (press release)

The company currently markets ZEGERID Capsules and ZEGERID Powder for Oral Suspension. These products are immediate-release formulations of omeprazole, ...

Posted: Thu Mar 06 04:58:23 -0500 2008

Santarus to Hold Fourth Quarter and Full Year 2007 Financial ... - Business Wire (press release)

The company’s current marketing efforts are primarily focused on ZEGERID ® Capsules and Powder for Oral Suspension. These products are immediate-release ...

http://www.businesswire.com/news/... | Posted: Thu Feb 21 04:01:28 -0500 2008

NEWS | SAN DIEGO Santarus announces launch of products in Puerto ... - San Diego Daily Transcript (subscription)

Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company headquartered in San Diego, today announced GlaxoSmithKline plc has launched ZEGERID ...

http://www.sddt.com/News/article.... | Posted: Tue Feb 19 11:21:37 -0500 2008

GlaxoSmithKline Sells Santarus Products In US Virgin Islands ... - Trading Markets (press release)

The Zegerid products were developed by Santarus Inc. (NASDAQ: SNTS). Santarus and GSK entered into a distribution agreement in November 2007 under which GSK ...

http://www.tradingmarkets.com/.si... | Posted: Tue Feb 19 09:35:44 -0500 2008

Santarus to Hold Fourth Quarter and Full Year 2007 Financial ... - PR-Inside.com (Pressemitteilung)

The company's current marketing efforts are primarily focused on ZEGERID(R) Capsules and Powder for Oral Suspension. These products are immediate-release ...

http://www.pr-inside.com/santarus... | Posted: Thu Feb 21 04:08:54 -0500 2008

Santarus reports GSK's launch of Zegerid products - Trading Markets (press release)

The Zegerid products were developed by Santarus and are the first and only immediate-release oral proton pump inhibitors (PPIs) commercialized in the US. ...

http://www.tradingmarkets.com/.si... | Posted: Tue Feb 19 13:22:26 -0500 2008

NEWS | SAN DIEGO Santarus announces launch of products in Puerto ... - San Diego Daily Transcript (subscription)

Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company headquartered in San Diego, today announced GlaxoSmithKline plc has launched ZEGERID ...

Posted: Tue Feb 19 11:21:37 -0500 2008

GlaxoSmithKline Sells Santarus Products In US Virgin Islands ... - Trading Markets (press release)

The Zegerid products were developed by Santarus Inc. (NASDAQ: SNTS). Santarus and GSK entered into a distribution agreement in November 2007 under which GSK ...

Posted: Tue Feb 19 09:35:44 -0500 2008

Santarus to Hold Fourth Quarter and Full Year 2007 Financial ... - PharmaLive.com (press release)

The company's current marketing efforts are primarily focused on ZEGERID(R) Capsules and Powder for Oral Suspension. These products are immediate-release ...

http://www.pharmalive.com/News/in... | Posted: Thu Feb 21 08:15:54 -0500 2008

PHARMA MARKET: Generic Protonix Gives Wyeth Heartburn - EasyBourse.com

Other heartburn drugs include Santarus Inc.'s (SNTX) Zegerid and AstraZeneca's Prilosec. Procter & Gamble (PG) markets an over-the-counter version of ...

http://www.easybourse.com/bourse-... | Posted: Thu Feb 07 13:20:55 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com